Immunogenicity and safety of two human papillomavirus vaccines for cervical cancer among Asian female populations : a systematic review
Cervical cancer is one of the common cancers among women and poses a great burden to the public health. Currently there are two human papillomavirus vaccines, CervarixTM and Gardasil®, against HPV type 16/18 and type 6/11/16/18 cervical cancer available in the market. Most clinical trials about immu...
Main Authors: | Zhao, Yingzi, 赵缨姿 |
---|---|
Language: | English |
Published: |
The University of Hong Kong (Pokfulam, Hong Kong)
2014
|
Subjects: | |
Online Access: | http://hdl.handle.net/10722/193778 |
Similar Items
-
Modeling the potential impact of HPV vaccination on Hong Kong's cervical cancer burden
by: Choi, Cheuk-wai, et al.
Published: (2014) -
Monitoring of female human papillomavirus carriers with background and precancer diseases of the cervix uteri
by: N. N. Zakhirova, et al.
Published: (2014-08-01) -
Typing of human papillomavirus in Western Cape women with cervical intraepithelial neoplasia
by: Kay, Patti Sheryl
Published: (2013) -
Human papillomavirus type distribution in cervical cancer in Indiana and Botswana
by: Qadadri, Brahim
Published: (2014) -
The role of human papillomavirus (HPV)-related molecular markers in cervical neoplasia, with emphasis on p-21 activated kinase type 1 (PAK 1)
by: Leung, Tsin-wah, et al.
Published: (2014)